Physician
Inland Empire Extra Care INC.
Inland Empire Extra Care INC. was paid $3.30M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoINLAND EMPIRE EXTRA CARE INC.
RANCHO CUCAMONGA, CA 91730
RANCHO CUCAMONGA, CA 91730
33aNPI1750551719assigned 03/06/2008
33bProvider typeThoracic Surgery (Cardiothoracic Vascular Surgery) Physician
28Total paid$3.30M
24GClaims96,938
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician providers in California
Rank by total paid#3 of 29
Median peer was paid$6K
This provider vs. median513×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,945 | $743K | |
| 2019 | 15,632 | $509K | |
| 2020 | 12,294 | $318K | |
| 2021 | 13,591 | $406K | |
| 2022 | 12,006 | $377K | |
| 2023 | 13,016 | $452K | |
| 2024incomplete | 16,454 | $493K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 25,879 | 23,546 | $998K |
| S9083 | Global fee urgent care centers | 29% | 13,857 | 12,129 | $957K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 23% | 10,772 | 10,741 | $743K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.2% | 5,400 | 5,382 | $304K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.4% | 10,069 | 9,524 | $244K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 516 | 504 | $30K |
| 99205 | Prolong outpt/office vis | <1% | 143 | 143 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,535 | 5,727 | $5K |
| 94760 | <1% | 4,231 | 3,904 | $3K | |
| 81002 | <1% | 4,734 | 4,538 | $583.50 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,874 | 1,814 | $431.45 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,387 | 2,329 | $410.82 |
25 more codes
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,539 | $362.55 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,692 | $344.21 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 27 | $330.54 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 72 | $217.95 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 162 | $206.49 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 956 | $181.03 |
| 99000 | <1% | 2,149 | $85.32 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 90 | $13.78 |
| 82962 | <1% | 41 | $5.28 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 581 | $0.45 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,173 | $0.29 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 141 | $0.00 |
| 69210 | 0% | 12 | $0.00 | |
| 81025 | 0% | 14 | $0.00 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 0% | 38 | $0.00 |
| A4465 | Non-elastic binder for extremity | 0% | 148 | $0.00 |
| A4550 | Surgical trays | 0% | 16 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 12 | $0.00 |
| 73600 | 0% | 37 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 379 | $0.00 |
| 87081 | 0% | 30 | $0.00 | |
| A4570 | Splint | 0% | 28 | $0.00 |
| 93000 | 0% | 25 | $0.00 | |
| 73120 | 0% | 20 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 159 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAZZAWI, ZAHER (DR/OWNER)